Reuters logo
BRIEF-Karo Bio posts bigger Q4 loss, announces rights issue 
February 12, 2016 / 7:37 AM / 2 years ago

BRIEF-Karo Bio posts bigger Q4 loss, announces rights issue 

Feb 12 (Reuters) -

* Karo bio ab says net sales increased to msek 69.1 (30.1), whereof q4 msek 57.4 (8.1)

* Karo bio ab says board of directors proposes that parent company changes name to karo pharma ab

* Net loss was MSEK 78.2 (-59.3), whereof q4 msek -24.7 (-21.8)

* Karo bio ab says underwriting agreements have been obtained for 100 per cent of issue, of which chairman Anders Lönner underwrites over 97 per cent. (Reporting By Johan Ahlander)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below